[Myocardial contractility and drug effects with special reference to the adrenergic mechanism].
D000109:Acetylcholine / Q000494:pharmacology; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D002395:Catecholamines / Q000494:pharmacology; D002415:Cats; D003864:Depression, Chemical; D004837:Epinephrine / Q000494:pharmacology; D004983:Ethanolamines / Q000494:pharmacology; D005934:Glucagon / Q000494:pharmacology; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects / Q000294:innervation* / Q000502:physiology; D010275:Parasympathetic Nervous System / Q000502:physiology*; D010643:Phenoxybenzamine / Q000494:pharmacology; D011817:Rabbits; D011941:Receptors, Adrenergic; D011950:Receptors, Cholinergic; D013564:Sympathetic Nervous System / Q000502:physiology*; D013963:Thyroid Hormones / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D004983:Ethanolamines; D011941:Receptors, Adrenergic; D011950:Receptors, Cholinergic; D013963:Thyroid Hormones; D010643:Phenoxybenzamine; D000804:Angiotensin II; D005934:Glucagon; D000109:Acetylcholine; D004837:Epinephrine